KRAS and neoplasm: In a mutant Kras-driven, Trp53-deleted NSCLC mouse model, lung adenocarcinoma activated osteocalcin-expressing osteoblastic cells in the bone marrow that remotely supply SiglecFhigh TANs to promote tumor growth [39].